Method for measuring blood coagulation

US9733262B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9733262-B2
Application numberUS-201514658911-A
CountryUS
Kind codeB2
Filing dateMar 16, 2015
Priority dateMay 20, 2009
Publication dateAug 15, 2017
Grant dateAug 15, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for measuring blood coagulation, including: preparing a reaction solution including a plasma specimen, a blood coagulation activator, and at least one of amino-guanidine and an acid addition salt thereof; and measuring blood coagulation time by detecting a turbidity change in the reaction solution.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for measuring blood coagulation, comprising: preparing a reaction solution comprising a plasma specimen, a blood coagulation activator, and at least one of amino-guanidine and an acid addition salt thereof; and measuring blood coagulation time by detecting a turbidity change in the reaction solution. 2. The method according to claim 1 , wherein the turbidity change is detected by a method of detecting a scattered light amount. 3. The method according to claim 1 , wherein the amino-guanidine or an acid addition salt thereof is added to the reaction solution together with a specimen diluent for measuring blood coagulation. 4. The method according to claim 2 , wherein the amino-guanidine or an acid addition salt thereof is added to the reaction solution together with a specimen diluent for measuring blood coagulation. 5. The method according to claim 3 , wherein the specimen diluent is a specimen diluent for measuring fibrinogen. 6. The method according to claim 4 , wherein the specimen diluent is a specimen diluent for measuring fibrinogen. 7. The method according to claim 1 , wherein the blood coagulation activator is thrombin. 8. The method according to claim 5 , wherein the blood coagulation activator is thrombin. 9. The method according to claim 6 , wherein the blood coagulation activator is thrombin. 10. The method according to claim 5 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 11. The method according to claim 6 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 12. The method according to claim 7 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 13. The method according to claim 9 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 14. The method according to claim 9 , wherein the measuring of blood coagulation time is performed by a fibrinogen measurement method. 15. The method according to claim 1 , wherein the reaction solution comprises amino-guanidine. 16. The method according to claim 1 , wherein the reaction solution comprises an acid addition salt of amino-guanidine. 17. The method according to claim 1 , wherein the acid addition salt of amino-guanidine is at least one salt selected from the group consisting of a hydrochloride salt of amino-guanidine, a sulfate salt of amino-guanidine, a nitrate salt of amino-guanidine, a phosphate salt of amino-guanidine, and a sulfamate salt of amino-guanidine. 18. The method according to claim 1 , wherein the at least one of amino-guanidine and an acid addition salt thereof is amino-guanidine hydrochloride. 19. The method according to claim 1 , wherein the amino-guanidine has the formula where R 1 is an amino group. 20. The method according to claim 17 , wherein the amino-guanidine has the formula where R 1 is an amino group.

Assignees

Inventors

Classifications

  • being further substituted by carboxyl groups · CPC title

  • Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors · CPC title

  • Compounds containing any of the groups [IMAGE cpc-sch-C07C-0974.gif], e.g. aminoguanidine · CPC title

  • G01N33/86Primary

    involving blood coagulating time {or factors, or their receptors} · CPC title

  • Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9733262B2 cover?
A method for measuring blood coagulation, including: preparing a reaction solution including a plasma specimen, a blood coagulation activator, and at least one of amino-guanidine and an acid addition salt thereof; and measuring blood coagulation time by detecting a turbidity change in the reaction solution.
Who is the assignee on this patent?
Sekisui Medical Co Ltd
What technology area does this patent fall under?
Primary CPC classification G01N33/86. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).